Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Gil and I will be your operator for today's call. At this time, I would like to welcome each and everyone of you to the Bio-Rat Second Quarter 2025 results conference call and webcast. All lines will be placed in mute to prevent any background noise. After the speakers remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to read your question, simply press star one again. It is now my pleasure to turn today's call over to Bio-Rat's head of investor relations, Mr. Edward Trump. Please go ahead. Good afternoon, everyone. And thank you for joining us. Today, we will review the Second Quarter 2025 financial results and provide an update on key business trends for Bio-Rat. With me on the call today are Norman Schwartz, our chief executive officer, John DiVincenzo, president and chief operating officer, and Rupe Lacaraju, executive vice president and chief financial officer. Before we begin our review, I'd like to remind everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals and expectations. You should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC, where we discuss in detail the risk factors in our business. The company does not intend to update any forward-looking statements made during the call today. Finally, our remarks today will in...